Cases & Deals

  • Home
  • Practices
  • Signal Pharmaceuticals develops global patent portfolio for small molecule therapeutics

Share

Signal Pharmaceuticals develops global patent portfolio for small molecule therapeutics

November 2008

Client(s) Signal Pharmaceuticals, LLC

Jones Day represents Signal Pharmaceuticals, LLC in the establishment of a global patent portfolio related to small molecules for the treatment of cancer.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.